Fostroxacitabine bralpamide

DB18090InvestigationalSmall molecule

Fostroxacitabine bralpamide: Overview.

Chemical structure of Fostroxacitabine bralpamide
Formula / weight
C22H30BrN4O8P · 589.38 g/mol (avg)
Also known as
Troxacitabine nucleotide prodrug miv-818
Code names
MIV-818

Resolves to

Compound
UNIIQ1I6YZ0NGFCAS2129993-56-0ChEMBLCHEMBL4594349
Structure
InChIKeyJBYKMODFCUCTGY-LLSQRQBFSA-NSMILESCCC[C@H](C)OC(=O)[C@H](C)N[P@](=O)(OC[C@H]1OC[C@H](O1)N1C=CC(N)=NC1=O)OC1=CC=C(Br)C=C1

What you can answer from here — as of September 12, 2026

1Clinical trialPhase, status and sponsor resolved per trial
Sign in

Which companies are running trials of Fostroxacitabine bralpamide, in which indications and phases, and which of those programs are still active?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In